E17K substitution in AKT1 in prostate cancer

BACKGROUND: The phosphatidylinositol 3-kinase (PI3K)–AKT pathway is activated in many cancers. Mutational hotspots in AKT1 and in the regulatory and catalytic subunits of PI3K have been detected in multiple tumour types. In AKT1, the E17K substitution leads to a PI3K-independent activation of AKT1....

Descripción completa

Detalles Bibliográficos
Autores principales: Boormans, J L, Korsten, H, Ziel-van der Made, A C J, van Leenders, G J L H, Verhagen, P C M S, Trapman, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869172/
https://www.ncbi.nlm.nih.gov/pubmed/20407443
http://dx.doi.org/10.1038/sj.bjc.6605673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869172/
https://www.ncbi.nlm.nih.gov/pubmed/20407443
http://dx.doi.org/10.1038/sj.bjc.6605673

Ejemplares similares